BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14510180)

  • 1. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine.
    Perbal B
    Expert Rev Mol Diagn; 2003 Sep; 3(5):597-604. PubMed ID: 14510180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCN3 protein and cancer.
    Perbal B
    Adv Exp Med Biol; 2006; 587():23-40. PubMed ID: 17163153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
    Perbal B
    Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN proteins and cancer: two to tango.
    Bleau AM; Planque N; Perbal B
    Front Biosci; 2005 May; 10():998-1009. PubMed ID: 15769600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.
    Heath E; Tahri D; Andermarcher E; Schofield P; Fleming S; Boulter CA
    BMC Dev Biol; 2008 Feb; 8():18. PubMed ID: 18289368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
    Yu C; Le AT; Yeger H; Perbal B; Alman BA
    J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOV/CCN3 impairs muscle cell commitment and differentiation.
    Calhabeu F; Lafont J; Le Dreau G; Laurent M; Kazazian C; Schaeffer L; Martinerie C; Dubois C
    Exp Cell Res; 2006 Jun; 312(10):1876-89. PubMed ID: 16600215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
    Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
    J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All in the CCN family: essential matricellular signaling modulators emerge from the bunker.
    Leask A; Abraham DJ
    J Cell Sci; 2006 Dec; 119(Pt 23):4803-10. PubMed ID: 17130294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
    Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
    J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCN family: a new stimulus package.
    Brigstock DR
    J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
    Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
    Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
    Böhlig L; Metzger R; Rother K; Till H; Engeland K
    Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.
    Bleau AM; Planque N; Lazar N; Zambelli D; Ori A; Quan T; Fisher G; Scotlandi K; Perbal B
    J Cell Biochem; 2007 Aug; 101(6):1475-91. PubMed ID: 17340618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
    Planque N; Long Li C; Saule S; Bleau AM; Perbal B
    J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for CCN3 (NOV) in calcium signalling.
    Li CL; Martinez V; He B; Lombet A; Perbal B
    Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
    Vallacchi V; Daniotti M; Ratti F; Di Stasi D; Deho P; De Filippo A; Tragni G; Balsari A; Carbone A; Rivoltini L; Parmiani G; Lazar N; Perbal B; Rodolfo M
    Cancer Res; 2008 Feb; 68(3):715-23. PubMed ID: 18245471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of ccn3(nov) gene in musculoskeletal tumors.
    Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
    Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.
    Minamizato T; Sakamoto K; Liu T; Kokubo H; Katsube K; Perbal B; Nakamura S; Yamaguchi A
    Biochem Biophys Res Commun; 2007 Mar; 354(2):567-73. PubMed ID: 17250806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the study of CCN family].
    Su BY; Cai WQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):179-83. PubMed ID: 12390824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.